Trial intelligence / Profile preview

Effect of tamsulosin on postoperative urinary retention after inguinal hernia repair under spinal anesthesia

IRCT20220131053898N1Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tamsulosin in postoperative urinary retention (POUR), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Incidence of postoperative urinary retention. Started Feb 2022; status: completed.

02

Drugs

tamsulosin
03

Conditions

postoperative urinary retention (POUR)

Beyond the preview

Go deeper on IRCT20220131053898N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220131053898N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call